SNOMED-CT

Brimochol shows increased visual acuity in clinical data


November 07, 2020

1 min watch


We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio Video Perspective from the virtual Eyecelerator conference, Ben Bergo, president and CEO, Visus Therapeutics, outlines the mechanism and clinical data of Brimochol, the company’s lead presbyopia-correcting eye drop candidate.



Source link

Most Popular

To Top